Strategene Gives Up Fight With Third Wave

After years of battling over genetic testing patents, molecular diagnostics company Stratagene Corp. has agreed to fork over $10.75 million to rival Third Wave Technologies Inc. as part of an out-of-court...

Already a subscriber? Click here to view full article